Imunon Inc Share Price Today: Live Updates & Key Insights

Imunon Inc share price today is $2.98, up -2.71%. The stock opened at $2.9569 against the previous close of $2.95, with an intraday high of $3.05 and low of $2.88.

Imunon Inc Share Price Chart

Imunon Inc

us-stock
To Invest in {{usstockname}}
us-stock

Imunon Inc Share Price Performance

$2.98 -0.0271(-2.71%) IMNN at 23 Mar 2026 01:39 PM Biotechnology
Lowest Today 2.88
Highest Today 3.05
Today’s Open 2.9569
Prev. Close 2.95
52 Week High 35.84
52 Week Low 2.86
Day’s Range: Low 2.88 High 3.05
52-Week Range: Low 2.86 High 35.84
1 day return -
1 Week return -1.69
1 month return -7.64
3 month return -22.25
6 month return -44.12
1 year return +176.19
3 year return +121.37
5 year return -90.49
10 year return -

Imunon Inc Institutional Holdings

Armistice Capital, LLC 7.85

DRW Securities, LLC 1.62

Vanguard Group Inc 1.09

Riverview Capital Advisers LLC 1.01

Geode Capital Management, LLC 0.62

Vanguard Total Stock Mkt Idx Inv 0.58

Fidelity Extended Market Index 0.45

UBS Group AG 0.32

Vanguard Institutional Extnd Mkt Idx Tr 0.30

NT Ext Equity Mkt Idx Fd - L 0.19

Morgan Stanley - Brokerage Accounts 0.13

BlackRock Inc 0.13

Wells Fargo & Co 0.10

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.07

Spartan Total Market Index Pool G 0.06

Fidelity Total Market Index 0.05

Fidelity Series Total Market Index 0.05

Northern Trust Extended Eq Market Idx 0.04

SBI Securities Co Ltd 0.03

NT Ext Equity Mkt Idx Fd - NL 0.01

Citigroup Inc 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Fidelity Nasdaq Composite Index 0.00

BNYM Mellon SL Market Completion UC1 0.00

Spartan Extended Market Index Pool F 0.00

Tower Research Capital LLC 0.00

Bank of America Corp 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

Group One Trading, LP 0.00

Federation des caisses Desjardins du Quebec 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Advisor Group Holdings, Inc. 0.00

Baader Bank INC 0.00

FMR Inc 0.00

Game Plan Financial Advisors, LLC 0.00

Steigerwald, Gordon & Koch Inc. 0.00

Imunon Inc Market Status

Strong Buy: 2

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Imunon Inc Fundamentals

Market Cap 9.76 M

PB Ratio 2.3909

PE Ratio 0.0

Enterprise Value 5.61 M

Total Assets 9.72 M

Volume 50631

Imunon Inc Company Financials

Annual Revenue FY23:125000 0.1M, FY22:500000 0.5M, FY21:500000 0.5M, FY20:500000 0.5M, FY19:500000 0.5M

Annual Profit FY23:null 0.0M, FY22:500000 0.5M, FY21:500000 0.5M, FY20:500000 0.5M, FY19:500000 0.5M

Annual Net worth FY23:-27859519 -27.9M, FY22:-35898000 -35.9M, FY21:-20769000 -20.8M, FY20:-21483561 -21.5M, FY19:-16851533 -16.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-167034 -0.2M, Q2/2025:-164674 -0.2M, Q1/2025:-2165092 -2.2M, Q3/2024:null 0.0M, Q2/2024:-185270 -0.2M

Quarterly Net worth Q3/2025:-3429124 -3.4M, Q2/2025:-2740559 -2.7M, Q1/2025:-4102495 -4.1M, Q3/2024:-4845475000 -4845.5M, Q2/2024:-4788017 -4.8M

About Imunon Inc & investment objective

Company Information Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Organisation Biotechnology

Employees 25

Industry Biotechnology

CEO Dr. Stacy R. Lindborg Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Imunon Inc FAQs

What is the share price of Imunon Inc today?

The current share price of Imunon Inc is $2.98.

Can I buy Imunon Inc shares in India?

Yes, Indian investors can buy Imunon Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Imunon Inc shares in India?

You can easily invest in Imunon Inc shares from India by:

Can I buy fractional shares of Imunon Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Imunon Inc?

Imunon Inc has a market cap of $9.76 M.

In which sector does Imunon Inc belong?

Imunon Inc operates in the Biotechnology sector.

What documents are required to invest in Imunon Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Imunon Inc?

The PE ratio of Imunon Inc is N/A and the PB ratio is 2.39.